Compounded GLP-1 Drugs Raise Safety Concerns

Compounded versions of GLP-1 drugs, including cheaper alternatives to Ozempic, are raising concerns among doctors and the FDA due to serious safety risks. While more accessible and affordable than brand-name medications, these compounded drugs lack equivalent regulatory oversight.

2 reports · 1 independentus_mainstream · other

Claim audit

No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.

All coverage